A molecular mechanism for signaling between seven-transmembrane receptors: evidence for a redistribution of G proteins

被引:18
作者
Djellas, Y
Antonakis, K
Le Breton, GC
机构
[1] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA
[2] Inst Rech Sci Canc, Unite Mixte Rech 133, CNRS, F-94801 Villejuif, France
关键词
D O I
10.1073/pnas.95.18.10944
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although activation of one seven-transmembrane receptor can influence the response of a separate seven-transmembrane receptor, e.g., the phenomenon of synergism, the underlying mechanism(s) for this signaling pro cess is unclear. The present study investigated communication between two receptors that exhibit classical synergism, e.g., human platelet thrombin and thromboxane A(2) receptors. Activation of thrombin receptors caused an increase in ligand affinity of thromboxane A(2) receptors. This effect (i) was shown to be specific, since a similar increase in ligand affinity was not caused by ADP or A23187; (ii) did not require cytosolic components, e.g., kinases, proteases, phosphatases, etc., because it occurred in isolated platelet membranes; (iii) was G protein-mediated because it was blocked by an G(alpha q) C terminus antibody; and (iv) was associated with a net increase in G(alpha q) coupling to thromboxane A(2) receptors. Collectively, these data provide evidence that seven-transmembrane receptors that share a common G(alpha) subunit can communicate with each other via a redistribution of their G proteins. Thus, activation of thrombin receptors increases G(alpha q) association with thromboxane A(2) receptors thereby shifting them to a higher affinity state. This signaling phenomenon, which modulates receptor-ligand affinity, may serve as a molecular mechanism for cellular adaptive processes such as synergism.
引用
收藏
页码:10944 / 10948
页数:5
相关论文
共 40 条
[21]  
HEDBERG A, 1988, J PHARMACOL EXP THER, V245, P786
[22]   CLONING AND EXPRESSION OF CDNA FOR A HUMAN THROMBOXANE-A2 RECEPTOR [J].
HIRATA, M ;
HAYASHI, Y ;
USHIKUBI, F ;
YOKOTA, Y ;
KAGEYAMA, R ;
NAKANISHI, S ;
NARUMIYA, S .
NATURE, 1991, 349 (6310) :617-620
[23]  
HSULIN SC, 1984, J BIOL CHEM, V259, P9121
[24]   PROSTAGLANDIN-F2-ALPHA ANTAGONIZES THROMBOXANE-A2 INDUCED HUMAN-PLATELET AGGREGATION [J].
HUNG, SC ;
GHALI, NI ;
VENTON, DL ;
LEBRETON, GC .
PROSTAGLANDINS, 1982, 24 (02) :195-206
[25]   Protease-activated receptor 3 is a second thrombin receptor in humans [J].
Ishihara, H ;
Connolly, AJ ;
Zeng, DW ;
Kahn, ML ;
Zheng, YW ;
Timmons, C ;
Tram, T ;
Coughlin, SR .
NATURE, 1997, 386 (6624) :502-506
[26]   Platelet-activating factor receptor: Gene expression and signal transduction [J].
Izumi, T ;
Shimizu, T .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1259 (03) :317-333
[27]   CHARACTERIZATION OF U46619 BINDING IN UNACTIVATED, INTACT HUMAN-PLATELETS AND DETERMINATION OF BINDING-SITE AFFINITIES OF 4 TXA2/PGH2 RECEPTOR ANTAGONISTS (13-APA, BM 13.177, ONO 3708 AND SQ 29,548) [J].
KATTELMAN, EJ ;
VENTON, DL ;
LEBRETON, GC .
THROMBOSIS RESEARCH, 1986, 41 (04) :471-481
[28]  
KIM SO, 1992, BIOCHEM PHARMACOL, V43, P313
[29]  
KNEZEVIC I, 1993, J BIOL CHEM, V268, P26011
[30]   THROMBIN-RECEPTOR AGONIST PEPTIDES, IN CONTRAST TO THROMBIN ITSELF, ARE NOT FULL AGONISTS FOR ACTIVATION AND SIGNAL-TRANSDUCTION IN HUMAN PLATELETS IN THE ABSENCE OF PLATELET-DERIVED SECONDARY MEDIATORS [J].
LAU, LF ;
PUMIGLIA, K ;
COTE, YP ;
FEINSTEIN, MB .
BIOCHEMICAL JOURNAL, 1994, 303 :391-400